Effects of endocannabinoid neurotransmission modulators on brain stimulation reward (Q48428879)

11 February 2018

title

Effects of endocannabinoid neurotransmission modulators on brain stimulation reward (English)

1 reference

11 February 2018

0 references

Styliani Vlachou

1

1 reference

11 February 2018

George G Nomikos

series ordinal

2

1 reference

11 February 2018

George Panagis

series ordinal

3

1 reference

11 February 2018

publication date

5 September 2006

1 reference

11 February 2018

published in

Psychopharmacology

1 reference

11 February 2018

volume

188

1 reference

11 February 2018

issue

3

1 reference

11 February 2018

page(s)

293-305

1 reference

11 February 2018

Role of endogenous cannabinoids in synaptic signaling

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0506-0

Are anandamide and cannabinoid receptors involved in ethanol tolerance? A review of the evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0506-0

Chronic ethanol consumption regulates cannabinoid CB1 receptor gene expression in selected regions of rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0506-0

The endocannabinoid system: physiology and pharmacology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0506-0

Cannabinoids and the regulation of ingestive behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0506-0

A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice.

21 January 2018

1 reference

12 December 2020

The endogenous cannabinoid system and the basal ganglia. biochemical, pharmacological, and therapeutic aspects.

1 reference

12 December 2020

Chemical and mutagenic investigations of fatty acid amide hydrolase: evidence for a family of serine hydrolases with distinct catalytic properties

1 reference

12 December 2020

Fitting intracranial self-stimulation data with growth models

1 reference

12 December 2020

Identification of the endogenous cannabinoid system through integrative pharmacological approaches

1 reference

12 December 2020

Cannabinoid receptors and reward in the rat: a conditioned place preference study.

1 reference

12 December 2020

Endocannabinoids and drug dependence

1 reference

12 December 2020

Cannabis and the brain

1 reference

12 December 2020

Genetic differences in delta 9-tetrahydrocannabinol-induced facilitation of brain stimulation reward as measured by a rate-frequency curve-shift electrical brain stimulation paradigm in three different rat strains.

1 reference

12 December 2020

Effects of CB1 cannabinoid receptor blockade on ethanol preference after chronic ethanol administration

1 reference

12 December 2020

Endovanilloids. Putative endogenous ligands of transient receptor potential vanilloid 1 channels

1 reference

12 December 2020

Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine

1 reference

12 December 2020

Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference

1 reference

12 December 2020

In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake

1 reference

12 December 2020

Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity

1 reference

12 December 2020

Reluctance of rats to drink hashish suspensions: free-choice and forced consumption, and the effects of hypothalamic stimulation

1 reference

12 December 2020

Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission.

1 reference

12 December 2020

Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats.

1 reference

12 December 2020

Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system

1 reference

12 December 2020

The curve-shift paradigm in self-stimulation

1 reference

12 December 2020

Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis

1 reference

12 December 2020

Modulation of transmitter release via presynaptic cannabinoid receptors

1 reference

12 December 2020

The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications

1 reference

12 December 2020

Intravenous self-administration of drugs in rats

1 reference

12 December 2020

Dopamine activation of endogenous cannabinoid signaling in dorsal striatum

1 reference

12 December 2020

Novel selective and metabolically stable inhibitors of anandamide cellular uptake

1 reference

12 December 2020

Cannabinoid receptors as therapeutic targets.

1 reference

12 December 2020

Failure to obtain "cannabis-directed behavior" and abstinence syndrome in rats chronically treated with cannabis sativa extracts

1 reference

12 December 2020

Evaluation of reinforcing capability of delta-9-tetrahydrocannabinol in rhesus monkeys

1 reference

12 December 2020

Effects of delta9-THC and WIN-55,212-2 on place preference in the water maze in rats

1 reference

12 December 2020

Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172.

1 reference

12 December 2020

THC-induced place and taste aversions in Lewis and Sprague-Dawley rats.

1 reference

12 December 2020

Conditioned taste aversion induced by self-administered drugs: paradox revisited

1 reference

12 December 2020

The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy

1 reference

12 December 2020

Modulation of anxiety through blockade of anandamide hydrolysis

1 reference

12 December 2020

(R)-methanandamide and Delta 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide

1 reference

12 December 2020

Therapeutic perspectives of inhibitors of endocannabinoid degradation.

1 reference

12 December 2020

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

1 reference

12 December 2020

WIN 55,212-2 decreases the reinforcing actions of cocaine through CB1 cannabinoid receptor stimulation

1 reference

12 December 2020

The endogenous cannabinoid anandamide and its synthetic analog R(+)-methanandamide are intravenously self-administered by squirrel monkeys

1 reference

12 December 2020

Endocannabinoids in the regulation of appetite and body weight

1 reference

12 December 2020

Self-administration of Δ9-tetrahydrocannabinol by rats

1 reference

12 December 2020

Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice

1 reference

12 December 2020

Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys.

1 reference

12 December 2020

The effects of systemic and intracerebral injections of D1 and D2 agonists on brain stimulation reward

1 reference

12 December 2020

A comparison of the discriminative stimulus effects of delta(9)-tetrahydrocannabinol and O-1812, a potent and metabolically stable anandamide analog, in rats

1 reference

12 December 2020

Endogenous cannabinoids as an aversive or counter-rewarding system in the rat.

1 reference

12 December 2020

Facilitation of brain stimulation reward by delta 9-tetrahydrocannabinol

1 reference

12 December 2020

The molecular logic of endocannabinoid signalling

1 reference

12 December 2020

Endogenous cannabinoid as a retrograde messenger from depolarized postsynaptic neurons to presynaptic terminals

1 reference

12 December 2020

Lipids as regulators of the activity of transient receptor potential type V1 (TRPV1) channels

1 reference

12 December 2020

The endocannabinoid signalling system: biochemical aspects

1 reference

12 December 2020

Functional role of high-affinity anandamide transport, as revealed by selective inhibition

1 reference

12 December 2020

Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice

1 reference

12 December 2020

A microcomputer-based method for physiologically interpretable measurement of the rewarding efficacy of brain stimulation

1 reference

12 December 2020

Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist

1 reference

12 December 2020

Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease.

1 reference

12 December 2020

The endogenous cannabinoid system and the treatment of marijuana dependence

1 reference

12 December 2020

Emesis, appetite, and endocannabinoids

1 reference

12 December 2020

Cannabinoid receptor gene (CNR1): association with i.v. drug use.

1 reference

12 December 2020

The endocannabinoid signaling system: pharmacological and therapeutic aspects

1 reference

12 December 2020

Effects of the cannabinoid receptor agonist CP 55,940 and the cannabinoid receptor antagonist SR 141716 on intracranial self-stimulation in Lewis rats

1 reference

12 December 2020

The endocannabinoid system and its therapeutic exploitation

1 reference

12 December 2020

Attenuation of spontaneous opiate withdrawal in mice by the anandamide transport inhibitor AM404.

1 reference

12 December 2020

Behavioral effects of cannabinoid agents in animals

1 reference

12 December 2020

Cannabinoids. I. Behavioral effects.

1 reference

12 December 2020

The effects of cannabinoids on the brain

1 reference

12 December 2020

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

1 reference

12 December 2020

The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids

1 reference

12 December 2020

Cannabinoid addiction: behavioral models and neural correlates.

1 reference

12 December 2020

The role of endocannabinoid transmission in cocaine addiction

1 reference

12 December 2020

Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716.

1 reference

12 December 2020

Effects of cocaine and GBR-12909 on brain stimulation reward

1 reference

12 December 2020

CB1 cannabinoid receptors and on-demand defense against excitotoxicity

1 reference

12 December 2020

Delta9-tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance

1 reference

12 December 2020

CB1 cannabinoid receptor agonists increase intracranial self-stimulation thresholds in the rat.

1 reference

12 December 2020

Lack of morphine-induced dopamine release in the nucleus accumbens of cannabinoid CB(1) receptor knockout mice

1 reference

12 December 2020

Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats

1 reference

12 December 2020

Functional neuroanatomy of the endocannabinoid system

1 reference

12 December 2020

Cannabinoid CB1 receptors control conditioned drug seeking

1 reference

12 December 2020

Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice

1 reference

12 December 2020

Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors

1 reference

12 December 2020

Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist

1 reference

12 December 2020

Discriminating between reward and performance: A critical review of intracranial self-stimulation methodology

1 reference

12 December 2020

Inhibitors of fatty acid amide hydrolase reduce carrageenan-induced hind paw inflammation in pentobarbital-treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors

1 reference

12 December 2020

Identification of a high-affinity binding site involved in the transport of endocannabinoids

1 reference

12 December 2020

Conditioned place preference induced by delta 9-tetrahydrocannabinol: comparison with cocaine, morphine, and food reward.

1 reference

12 December 2020

Cognitive consequences of cannabis use: comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions

1 reference

12 December 2020

New perspectives in the studies on endocannabinoid and cannabis: abnormal behaviors associate with CB1 cannabinoid receptor and development of therapeutic application

1 reference

12 December 2020

Parametric analysis of brain stimulation reward in the rat: III. Effect of performance variables on the reward summation function.

1 reference

12 December 2020

Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain

1 reference

12 December 2020

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

1 reference

12 December 2020

Delta 9-tetrahydrocannabinol: aversive effects in rat at high doses.

1 reference

12 December 2020

Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphine

1 reference

12 December 2020

Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.

1 reference

12 December 2020

Failure of Delta(9)-tetrahydrocannabinol and CP 55,940 to maintain intravenous self-administration under a fixed-interval schedule in rhesus monkeys

1 reference

12 December 2020

Anxiolytic-like properties of the anandamide transport inhibitor AM404.

1 reference

12 December 2020

Endocannabinoid system and stress and anxiety responses.

1 reference

12 December 2020

Self-administration of delta9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys

1 reference

12 December 2020

The effect of the enzyme inhibitor phenylmethylsulfonyl fluoride on the pharmacological effect of anandamide in the mouse model of cannabimimetic activity.

1 reference

12 December 2020

Cannabinoid agonists but not inhibitors of endogenous cannabinoid transport or metabolism enhance the reinforcing efficacy of heroin in rats

1 reference

12 December 2020

Anandamide and vanilloid TRPV1 receptors

1 reference

12 December 2020

Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses

1 reference

12 December 2020

Behavioral pharmacological properties of a novel cannabinoid 1',1'-dithiolane delta8-THC analog, AMG-3.

1 reference

12 December 2020

Construct validity of a self-stimulation threshold paradigm: Effects of reward and performance manipulations

1 reference

12 December 2020

Endocannabinoid system and opioid addiction: behavioural aspects.

1 reference

12 December 2020

Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data

1 reference

12 December 2020

Aversive effects of the synthetic cannabinoid CP 55,940 in rats.

1 reference

12 December 2020

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

1 reference

12 December 2020

10.1007/S00213-006-0506-0

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018